Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease-Reference-Cited by-同舟云学术

Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease

Published:2013-02-12 Issue:7 Volume:260 Page:1724-1730
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Picillo Marina,Erro Roberto,Santangelo Gabriella,Pivonello Rosario,Longo Katia,Pivonello Claudia,Vitale Carmine,Amboni Marianna,Moccia Marcello,Colao Annamaria,Barone Paolo,Pellecchia Maria Teresa

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-013-6851-0.pdf

Reference29 articles.

1. Braak H, Del Tredici K, Rub U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

2. Guan J, Krishnamurthi R, Waldvogel HJ et al (2000) N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 859:286e92

3. Quesada A, Lee BY, Micevych PE (2008) PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson’s disease. Dev Neurobiol 68:632e44

4. Offen D, Shtaif B, Hadad D et al (2001) Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease. Neurosci Lett 316:129e32

5. Sutherland GT, Matigian NA, Chalk AM et al (2009) A cross-study transcriptional analysis of Parkinson’s disease. PLoS ONE 4(3):e4955

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson’s Disease: A systematic review and meta-analysis;Ageing Research Reviews;2023-12

2. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease;BMC Neurology;2023-10-06

3. Gender differences in non-motor fluctuations in Parkinson’s disease;Journal of Neural Transmission;2023-08-01

4. Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson’s disease;European Archives of Oto-Rhino-Laryngology;2023-06-01

5. Age and sex differentially shape brain networks in Parkinson's disease;CNS Neuroscience & Therapeutics;2023-03-08